In tumor biopsies, studies of other peroxiredoxins, such as peroxiredoxin 5 or peroxiredoxin 1 have demonstrated that their expression before any treatment is able to predict clinical outcomes [38,39]. Here, PRDX1 is linked to neoplasm.